Literature DB >> 15228251

Envenoming by Bothrops jararaca in Brazil: association between venom antigenaemia and severity at admission to hospital.

F O S França1, K C Barbaro, H W Fan, J L C Cardoso, I S Sano-Martins, S C Tomy, M H Lopes, D A Warrell, R D G Theakston.   

Abstract

The association between the clinical severity of Bothrops jararaca envenoming at admission and serum venom and plasma fibrinogen concentrations before antivenom administration is reported in 137 patients admitted to Hospital Vital Brazil, Instituto Butantan, São Paulo, Brazil, between 1989 and 1990. Other variables such as age, gender, site of the bite, use of tourniquet and the time interval between the bite and start of antivenom therapy, spontaneous systemic bleeding, and the 20 minute whole blood clotting test (20WBCT) at admission showed no association with either severity or serum venom antigen concentration (SVAC). Mean SVAC in patients with mild envenoming was significantly lower than in the group with moderate envenoming (P = 0.0007). Patients with plasma fibrinogen concentrations > 1.5 g/L had a lower mean SVAC than patients with plasma fibrinogen concentrations < or = 1.5 g/L (P = 0.02). Those admitted with a tourniquet in place had significantly higher plasma fibrinogen concentrations than those without a tourniquet (P = 0.002). A multiple logistic regression model showed independent risk factors for severity: bites at sites other than legs or forearms, SVACs > or = 400 ng/mL, and the use of a tourniquet. Rapid quantification of SVAC before antivenom therapy might improve initial evaluation of severity in B. jararaca bites.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 15228251     DOI: 10.1016/s0035-9203(03)90158-1

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  7 in total

1.  Crotaline snake bite in the Ecuadorian Amazon: randomised double blind comparative trial of three South American polyspecific antivenoms.

Authors:  Roger Smalligan; Judy Cole; Narcissa Brito; Gavin D Laing; Bruce L Mertz; Steven Manock; Jeffrey Maudlin; Brad Quist; Gary Holland; Stephen Nelson; David G Lalloo; Gonzalo Rivadeneira; Maria Elena Barragan; Daniel Dolley; Michael Eddleston; David A Warrell; R David G Theakston
Journal:  BMJ       Date:  2004-11-13

Review 2.  Secreted phospholipases A2 of snake venoms: effects on the peripheral neuromuscular system with comments on the role of phospholipases A2 in disorders of the CNS and their uses in industry.

Authors:  John B Harris; Tracey Scott-Davey
Journal:  Toxins (Basel)       Date:  2013-12-17       Impact factor: 4.546

Review 3.  The Treatment of Snake Bites in a First Aid Setting: A Systematic Review.

Authors:  Bert Avau; Vere Borra; Philippe Vandekerckhove; Emmy De Buck
Journal:  PLoS Negl Trop Dis       Date:  2016-10-17

4.  Acute kidney failure following severe viper envenomation: clinical, biological and ultrasonographic aspects.

Authors:  Blaise Adelin Tchaou; Kofi-Mensa Savi de Tové; Charles Frédéric Tchégnonsi N'Vènonfon; Patrick Kouomboua Mfin; Abdou-Rahman Aguemon; Martin Chobli; Jean-Philippe Chippaux
Journal:  J Venom Anim Toxins Incl Trop Dis       Date:  2020-12-07

5.  Reports of Doses Administered and Adverse Reactions to Snake Antivenom Used in Uruguay in 2018.

Authors:  Alba Negrin; María Alejandra Battocletti; Carolina Juanena; Victor Morais
Journal:  Front Toxicol       Date:  2021-08-27

6.  Vulnerabilities in snakebites in Sao Paulo, Brazil.

Authors:  Maria Rita Bertolozzi; Camila Morato da Conceição Scatena; Francisco Oscar de Siqueira França
Journal:  Rev Saude Publica       Date:  2015-11-24       Impact factor: 2.106

Review 7.  Bedside Coagulation Tests in Diagnosing Venom-Induced Consumption Coagulopathy in Snakebite.

Authors:  Supun Wedasingha; Geoffrey Isbister; Anjana Silva
Journal:  Toxins (Basel)       Date:  2020-09-10       Impact factor: 4.546

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.